These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28316751)

  • 1. Microscopic characterization of Pseudomonas Aeruginosa confines separate from clinical cases by testing RAPD-PCR method.
    Mahmmudi Z; Emami A; Gorzin AA
    J Med Life; 2015; 8(Spec Iss 4):319-323. PubMed ID: 28316751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of polymorphisms among
    Parsa P; Amirmozafari N; Nowruzi B; Bahar MA
    Heliyon; 2020 Dec; 6(12):e05041. PubMed ID: 33376816
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotyping of Pseudomonas aeruginosa strains isolated from burn patients by RAPD-PCR.
    Nanvazadeh F; Khosravi AD; Zolfaghari MR; Parhizgari N
    Burns; 2013 Nov; 39(7):1409-13. PubMed ID: 23773789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to antibiotics in clinical isolates of Pseudomonas aeruginosa.
    Sevillano E; Valderrey C; Canduela MJ; Umaran A; Calvo F; Gallego L
    Pathol Biol (Paris); 2006; 54(8-9):493-7. PubMed ID: 17027190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of Metallo-Beta-Lactamase and alginate in multidrug resistance
    Qader GM; Jarjees KK; Jarjees RK
    J Med Life; 2022 Sep; 15(9):1105-1109. PubMed ID: 36415531
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular characterizations of antibiotic resistance, biofilm formation, and virulence determinants of Pseudomonas aeruginosa isolated from burn wound infection.
    Ghasemian S; Karami-Zarandi M; Heidari H; Khoshnood S; Kouhsari E; Ghafourian S; Maleki A; Kazemian H
    J Clin Lab Anal; 2023 Apr; 37(4):e24850. PubMed ID: 36808649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity and molecular analysis of metallo beta lactamases among imipenem resistant clinical isolates of
    Ali A; Ahmad K; Rahat S; Ahmad I
    Pak J Med Sci; 2021; 37(7):1865-1870. PubMed ID: 34912409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran.
    Ranjbar R; Owlia P; Saderi H; Mansouri S; Jonaidi-Jafari N; Izadi M; Farshad S; Arjomandzadegan M
    Acta Med Iran; 2011; 49(10):675-9. PubMed ID: 22071644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of multidrug-resistant Pseudomonas aeruginosa isolated from drinking water and hospitalized patients in Jordan.
    Tarazi YH; Abu-Basha E; Ismail ZB; Al-Jawasreh SI
    Acta Trop; 2021 May; 217():105859. PubMed ID: 33582141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study.
    Mladenovic-Antic S; Kocic B; Velickovic-Radovanovic R; Dinic M; Petrovic J; Randjelovic G; Mitic R
    J Clin Pharm Ther; 2016 Oct; 41(5):532-7. PubMed ID: 27511808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021.
    Lee YL; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2023 Aug; 62(2):106867. PubMed ID: 37244423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints.
    Gupta V; Yu KC; Pogue JM; Watts JA; Clancy CJ
    Microbiol Spectr; 2022 Jun; 10(3):e0115822. PubMed ID: 35638777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of blaPER-1 & blaOxa10 among imipenem resistant isolates of Pseudomonas aeruginosa isolated from burn patients hospitalized in Shiraz Burn Hospital.
    Emami A; Bazargani A; Mohammadi AA; Zardosht M; Seyed Jafari SM
    Iran J Microbiol; 2015 Feb; 7(1):7-11. PubMed ID: 26644867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-Resistance Genes in Pseudomonas aeruginosa from Wound Infections in a Tertiary Health Institution in Osogbo, Nigeria.
    Akinloye AO; Adefioye JO; Adekunle CO; Anomneze BU; Makanjuola OB; Onaolapo OJ; Onaolapo AY; Olowe OA
    Infect Disord Drug Targets; 2021; 21(1):90-98. PubMed ID: 31957616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
    J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in Vitro Activity of Doripenem versus Old Carbapenems against Pseudomonas Aeruginosa Clinical Isolates from both CF and Burn Patients.
    Hojabri Z; Ahangarzadeh Rezaee M; Nahaei MR; Soroush MH; Ghojazadeh M; Pirzadeh T; Davodi M; Ghazi M; Bigverdi R; Pajand O; Aghazadeh M
    Adv Pharm Bull; 2013; 3(1):121-5. PubMed ID: 24312823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in
    Hassuna NA; Darwish MK; Sayed M; Ibrahem RA
    Infect Drug Resist; 2020; 13():285-293. PubMed ID: 32099420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.